There are a lot of reasons to avoid hospitals, but many people are ignorant to some of the worst dangers lurking in those hallways. Sure, there is a higher danger for catching airborne illnesses like head colds or influenza in these buildings, but there’s one factor that worries me much more. Since most hand sanitizer is made with alcohol, this is predominantly what you find in hand sanitizers in most medical buildings. However, while alcohol can destroy influenza and cold particles, it is completely ineffective against clostridium difficile colitis, or c. difficile. C. difficile is a severe bacterial infection in the gut that can cause patients to be sick for weeks with fevers, diarrhea, abdominal cramping, and chills. Although originally assumed to only be caused by pernicious bacteria, c. difficile infections now include a unique fungus that isn’t present in patients without the disorder, which potentially leads to it being so resistant to treatment and disinfectants when it’s on surfaces like doorknobs and sink faucets. This is where antimicrobial research of minor cannabinoids comes into play. We need as many options for both disinfectants and medications used to treat the infections once they spread in the body. Cannabigerol (CBG) is showing significant antimicrobial effects in clinical studies. If CBG in high concentrations could effectively treat bacterial infections in the body, it could lead to new treatments that were never available previously. Whether or not it would be strong enough to combat c. difficile specifically is yet to be seen, but we need every option available in the arsenal when dealing with pernicious bacteria.